Fact checked by Nick Blackmer Novo Nordisk launched a direct-to-consumer program last week to sell Wegovy at a reduced price ...
Novo Nordisk is cutting the price of its weight-loss drug, Wegovy, and selling it through a direct-to-patient online pharmacy ...
The pharmacy, called NovoCare, will allow patients to pay $499 in cash per month for the blockbuster weight loss drug.
The Food and Drug Administration in February removed Wegovy from its shortage list and told compounders to cease selling their cheaper copies in the coming months, having removed Zepbound in December.
Novo Nordisk (NVO), the maker of the blockbuster drug Ozempic, is cutting the price of its weight loss drug by more than half ...
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices ... The price cuts come as supplies improve.
The offer may show employers how hard drug manufacturers will compete based on price, in at least some situations.
Makers of the popular obesity treatments Wegovy and Zepbound ... as supplies improve. The U.S. Food and Drug Administration has moved both drugs off its list of medicines in shortage.